GP

Goudy Park Capital

North America, Illinois, United States, Chicago

Description

Goudy Park Capital is an investment advisory firm based in Chicago, Illinois.

Investor Profile

Goudy Park Capital has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series B (33%)
  • Series C (33%)
  • Series A (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Goudy Park Capital frequently co-invest with?

New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 2
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 2
Genesys Capital
North America, Ontario, Canada, Toronto
Co-Investments: 2
Longitude Capital
North America, California, United States, Menlo Park
Co-Investments: 2
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 2
Beecken Petty O'Keefe & Company
North America, Illinois, United States, Chicago
Co-Investments: 2
Adams Street Partners
North America, Illinois, United States, Chicago
Co-Investments: 3
Latterell Venture Partners
North America, California, United States, San Francisco
Co-Investments: 3
P
North America, Illinois, United States, Northbrook
Co-Investments: 3

What are some of recent deals done by Goudy Park Capital?

Aptinyx

Evanston, Illinois, United States

Aptinyx Inc. is a biopharmaceutical company.

BiopharmaBiotechnologyHealth CareMedical
Series BDec 18, 2017
Amount Raised: $70,000,000
Aptinyx

Evanston, Illinois, United States

Aptinyx Inc. is a biopharmaceutical company.

BiopharmaBiotechnologyHealth CareMedical
Series AMay 10, 2016
Amount Raised: $65,000,000
Naurex

Evanston, Illinois, United States

Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

BiopharmaBiotechnologyTherapeutics
Series CDec 3, 2014
Amount Raised: $80,000,000